Tarceva

Erlotinib Hydrochloride

8.0 High risk

Tarceva & Rash

23.5%

of users reported Rash

51.0%

also reported Severe reaction

56.8%

are women

Most common medical consequences

Severe reaction
51.0%
Death
23.9%
Hospitalization
21.9%
Disability
2.5%
Life-threatening condition
0.7%

Have you experienced any negative side effects from this medication?

Tarceva: general information

Most common side effects (196)

Most commonly affected ages

30 - 39 years
0.6%
40 - 49 years
4.2%
50 - 59 years
16.4%
60 - 69 years
29.1%
70 - 79 years
31.4%
80 - 89 years
16.6%
90 - 99 years
1.7%